Financière de Tubize SA (LON:0D53)

Market Cap	7.91B +56.8%
Revenue (ttm)	n/a
Net Income	81.33M +3.5%
EPS	1.83 +3.5%
Shares Out	n/a
PE Ratio	97.21
Forward PE	n/a
Dividend	0.65 (0.33%)
Ex-Dividend Date	May 7, 2026

Volume	2
Average Volume	976
Open	203.80
Previous Close	201.60
Day's Range	203.80 - 205.20
52-Week Range	115.00 - 250.50
Beta	0.37
RSI	47.93
Earnings Date	Mar 21, 2026

About Financière de Tubize

Financière de Tubize SA holds a stake in UCB, a biopharmaceutical company in Belgium. It focuses on the discovery and development of treatments for patients suffering from diseases affecting immune or central nervous system. The company was founded in 1928 and is based in Brussels, Belgium.

• Industry: Investors, not elsewhere classified
• Founded: 1928
• Employees: 3
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0D53

Financial Performance

Financial numbers in EUR